Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001326110-23-000050
Filing Date
2023-04-28
Accepted
2023-04-28 16:24:34
Documents
23

Document Format Files

Seq Description Document Type Size
1 DEF 14A ibrx-20230427.htm   iXBRL DEF 14A 892014
6 ibrx-20230427_g1.jpg GRAPHIC 1144
7 ibrx-20230427_g2.jpg GRAPHIC 32624
8 ibrx-20230427_g3.jpg GRAPHIC 231252
9 ibrx-20230427_g4.jpg GRAPHIC 29353
10 ibrx-20230427_g5.jpg GRAPHIC 4270
11 ibrx-20230427_g6.jpg GRAPHIC 110927
12 ibrx-20230427_g7.jpg GRAPHIC 106153
13 ibrx-20230427_g8.jpg GRAPHIC 2138605
14 ibrx-20230427_g9.jpg GRAPHIC 1966648
  Complete submission text file 0001326110-23-000050.txt   10885754

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20230427.xsd EX-101.SCH 3311
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ibrx-20230427_def.xml EX-101.DEF 4239
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20230427_lab.xml EX-101.LAB 5753
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20230427_pre.xml EX-101.PRE 3244
17 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20230427_htm.xml XML 97757
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37507 | Film No.: 23866848
SIC: 2836 Biological Products, (No Diagnostic Substances)